BioMedVic signs a joint statement on Health R&D

BioMedVic’s CEO, Prof Jan Tennent, has signed a joint industry pre-election statement on health research and development (R&D). The statement defends the need for industry-driven R&D and urges that the R&D Tax Incentive be preserved for the sector in order to reverse the declining trend of R&D investment in Australia.

Development of the joint statement was led by AusBiotech and has been signed, together with BioMedVic, by the CEOs of AusBiotech, Medicines Australia, MTAA, ARCS Australia, BioMelbourne Network and Research Australia.

Read the Media Release here.